Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

James Calvert webinar banner 3x2

Chronic obstructive pulmonary disease: managing breathlessness

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103138  Date of preparation: November 2020

Asthma webinar image

What are our options for children with severe asthma?

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103140  Date of preparation: November 2020

COPD webinar image

The appropriate use of inhaled corticosteroids (ICS) in COPD

Commissioned by Boehringer Ingelheim Limited

This promotional webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. The webinar is intended for UK healthcare professionals.

PC-GB-103139  Date of preparation: November 2020

Takeda webinar promotion  index image

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd.

Trajenta animation updated index image

Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

Screen Shot 2020-02-25 at 15.20.11

Fencino® (fentanyl transdermal patch): clinical and practical considerations

Commissioned by Ethypharm UK Ltd

This animation has been commissioned and funded by Ethypharm UK Ltd and developed in partnership with Guidelines in Practice.
Download prescribing information and adverse event statement
UK-FEN-27   Date of Preparation: November 2020

5-minute video_Chronic respiratory conditions and COVID-19-v2

NICE guidance on respiratory conditions and COVID-19: 5-minute video

By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones highlights important things you need to know about managing respiratory conditions in a COVID-19 context

Coronavirus visualisation dark

Death certification in COVID-19: 5-minute video

By

Dr Toni Hazell highlights important things you need to know about changes to death certification processes during the COVID-19 outbreak

Soprobec FDG index image

Soprobec (beclometasone dipropionate) pMDI

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 December 2020

Nutramigen Puramino Index Image

Nutramigen* PURAMINO*

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020

Nutramigen LGG Index Image

Nutramigen* 1, 2 & 3 LGG®

Commissioned by Mead Johnson Nutrition

This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020

Index Image Doptelet FDG_v7 October DOP

Doptelet®▼(Avatrombopag)

Commissioned by Swedish Orphan Biovitrum Ltd

This formulary decision guide was developed from content provided by Swedish Orphan Biovitrum Ltd in a format developed by Guidelines in Practice
View prescribing information and adverse events reporting
PP-9170

20201016 Saxenda FDG digital V2 image

Formulary decision guide: Saxenda® (liraglutide injection 3 mg)

Commissioned by Novo Nordisk

This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only. 
Click here for the Prescribing Information and Adverse Events Reporting.

UK20SX00110
Date of preparation: October 2020

Stalpex FDG Update index image

Stalpex (salmeterol xinafoate/fluticasone propionate)

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-STAL-0045 December 2020

Index image_Soprobec supplement_PI update

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement that aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Eliquis supplement index image

Updates in venous thromboembolism management—a haematologist’s perspective

Commissioned by BMS – Pfizer Alliance

This supplement has been commissioned and funded by the BMS-Pfizer Alliance and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals.
View prescribing and adverse event reporting information

PP-ELI-GBR-7703 November 2020

Leeds supplement_digital_index image

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Celltrion supplement cover

Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust

Commissioned by Celltrion Healthcare UK Ltd

This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D (1) October 2020

FINAL Psoriasis supplement index image

High cost drugs in psoriasis: how to optimise patient care and budgets

Commissioned by Almirall Ltd

This supplement has been commissioned and funded by Almirall Ltd and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals only.
UK-NOP-2000055

Optimised patient pathway for infertility

An optimised patient pathway for the treatment of heterosexual patients with infertility

Commissioned by Merck Serono Ltd

This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

20200311 DPP-4 inhibitor GinP supplement v10 digital version draft

Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities

Commissioned by Boehringer Ingelheim Limited

This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

ICS consensus

How should inhaled steroids be used in the management of asthma in adults within a primary care setting?

Supported by an educational grant from CIPLA EU Ltd

Information intended for healthcare professionals only.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

FINAL Allergic rhinitis checklist image

Implementing the Guidelines algorithm on identifying and managing allergic rhinitis in the asthma population

Supported by an educational grant from Mylan

Information intended for healthcare professionals only.

PCDS acne checklist

Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for acne vulgaris

Supported by an educational grant from Galderma UK Ltd

Information intended for healthcare professionals only.

20201022 SMC card hosting page image new PI V1

▼Brolucizumab (Beovu®) 120mg/mL solution for injection in pre-filled syringe SMC2272

Commissioned by Novartis Pharmaceuticals UK Ltd

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. Information intended for healthcare professionals only.
Click here for Prescribing information and Adverse Event Reporting.

BEO20-C089b (1)
Date of preparation: October 2020

Trajenta diabetes flyer v18 cover

Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited.

Cost benefits eczema

Cost-benefit of prescribing emollients for eczema patients

Commissioned by Johnson & Johnson Limited

The content of this infographic has been developed by Johnson & Johnson Ltd.

Fostair Logo

Fostair (beclometasone/formoterol): key messages

Commissioned by Chiesi Ltd

This promotional resource has been commissioned and developed by Chiesi Limited. Information intended for UK healthcare professionals only.
Click here for Prescribing Information and Adverse Event Reporting.

UK-NEX-2000037 November 2020

Takeda logo

Case study on Type 2 diabetes management: implementation of a DPP-4 inhibitor switch strategy across a primary care network

Commissioned by Takeda UK Ltd

This advertorial has been commissioned and developed by Takeda UK Ltd.

Resources (which contain promotional information) provided by Norgine.
UKE-HEP-XIF-2000005 Date of preparation: January 2021
  • Best practice in hepatic encephalopathy

  • Consensus statement: identification and management of hepatic encephalopathy